193902-81-7

• 常用中文名：4-(4-Boc-哌嗪-1-基)-3-氯苯胺
• 常用英文名：4-(4-BOC-PIPERAZIN-1-YL)-3-CHLOROANILINE
• CAS号：193902-81-7
• 分子式：C₁₅H₂₂ClN₃O₂
• 分子量：311.80700
• 发布时间：2018-12-28 18:28:07
• 更新时间：2024-01-28 16:42:45

名称

• 中文名: 4-(4-Boc-哌嗪-1-基)-3-氯苯胺
• 英文名: tert-butyl 4-(4-amino-2-chlorophenyl)piperazine-1-carboxylate
• 英文别名: tert-butyl-4-(4-amino-2-chlorophenyl)piperazine-1-carboxylate; 4-(4-amino-2-chlorophenyl)piperazine-1-carboxylic acid tert-butyl ester; 4-(4-Boc-piperazin-1-yl)-3-chloroaniline; 3-Chloro-4-(4-t-butoxycarbonyl-1-piperazinyl)aniline

物化性质

• 密度: 1.226g/cm3
• 沸点: 467.3ºC at 760 mmHg
• 分子式: C₁₅H₂₂ClN₃O₂
• 分子量: 311.80700
• 闪点: 236.4ºC
• 精确质量: 311.14000
• PSA: 58.80000
• LogP: 3.56340
• 蒸汽压: 6.57E-09mmHg at 25°C
• 折射率: 1.574

安全

• 海关编码: 2933599090

合成路线

193902-80-6 ~72% 193902-81-7

文献：Sankyo Company, Limited Patent: EP1764360 A1, 2007 ; Location in patent: Page/Page column 161 ; EP 1764360 A1

350-30-1 ~% 193902-81-7

文献：VanderWel, Scott N.; Harvey, Patricia J.; McNamara, Dennis J.; Repine, Joseph T.; Keller, Paul R.; Quin III, John; Booth, R. John; Elliott, William L.; Dobrusin, Ellen M.; Fry, David W.; Toogood, Peter L. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2371 - 2387

57260-71-6 ~% 193902-81-7

文献：VanderWel, Scott N.; Harvey, Patricia J.; McNamara, Dennis J.; Repine, Joseph T.; Keller, Paul R.; Quin III, John; Booth, R. John; Elliott, William L.; Dobrusin, Ellen M.; Fry, David W.; Toogood, Peter L. Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2371 - 2387

29682-39-1 57260-71-6 ~% 193902-81-7

文献：ABBOTT LABORATORIES; ABBOTT LABORATORIES TRADING (SHANGHAI) COMPANY, LTD.; VASUDEVAN, Anil; PENNING, Thomas Dale; CHEN, Huanming; LIANG, Bo; WANG, Shaohui; WU, Fengchun; SHEN, Yan; LIU, Cuihua; ZOU, Zhenguang Patent: WO2012/97684 A1, 2012 ; WO 2012/097684 A1

上下游产品

上游产品  3
350-30-1 57260-71-6 29682-39-1
下游产品  0

海关

海关编码	2933599090
中文概述	2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%